Item 7.01 Regulation FD Disclosure.
On December 13, 2019, West Pharmaceutical Services, Inc. (the "Company") issued
a press release announcing that its Board of Directors (the "Board") approved a
first-quarter 2020 dividend of $0.16 per share. The dividend will be paid on
February 5, 2020, to shareholders of record as of January 22, 2020. The Company
also announced that its Board authorized a share repurchase program for
calendar-year 2020, as described in Item 8.01 below.
On December 10, 2019, the Company appointed Charles Witherspoon, Vice President,
Treasury, to the role of Vice President and Treasurer, effective immediately.
The role of Treasurer was previously held by Bernard J. Birkett, Senior Vice
President and Chief Financial Officer. Mr. Birkett will continue to serve as
Senior Vice President and Chief Financial Officer of the Company.
On January 15, 2020, the Company will present an overview of its business at the
J.P. Morgan Healthcare Conference in San Francisco, California, at 4:30 PM
Pacific Time.
The information in this report (including Exhibit 99.1) is being furnished
pursuant to Item 7.01 and shall not be deemed "filed" for purposes of Section 18
of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or
otherwise subject to the liabilities of that section, nor will it be
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by specific
referencing in such filing.
Item 8.01 Other Events.
On December 10, 2019, the Company's Board authorized a share repurchase program
for calendar-year 2020 authorizing the repurchase of up to 848,000 shares of the
Company's common stock from time to time on the open market or in
privately-negotiated transactions as permitted under Exchange Act Rule 10b-18.
The number of shares to be repurchased and the timing of such transactions will
depend on a variety of factors, including market conditions. The share
repurchase program is expected to be completed by December 31, 2020. The
Company's previously-authorized share repurchase program will expire on December
31, 2019.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibit No. Description
99.1 West Pharmaceutical Services, Inc. Press Release, dated
December 13, 2019.
104 The cover page from the Company's Current Report on Form 8-K,
dated December 10, 2019, formatted in Inline XBRL.
2
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses